Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Cancer Research
Published October 1, 2026
FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Foll...
October 2, 2026
Medspoke
Medspoke
Cancer Discovery
Published October 1, 2026
00:00
--:--
Genomic alterations and treatment define spatiotemporal patterns of glioblastoma recurrence.
October 2, 2026
Share
Genomic alterations and treatment define spatiotemporal patterns of glioblastoma recurrence.
https://www.medspoke.co/channel_journal?id=686&tap_id=14930
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
JAMA Oncology
Published October 1, 2026
Rethinking Value in Cancer Care in the US.
October 2, 2026
Why are you reporting this TALK?
